[Dose-related effects of the polyene antifungal drug natamycin in a galenic form of newly developed suppository in vaginal yeast infections].
D000293:Adolescent; D000328:Adult; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003022:Clotrimazole / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008825:Miconazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D010866:Natamycin / Q000008:administration & dosage* / Q000627:therapeutic use; D013488:Suppositories
D013488:Suppositories; D008825:Miconazole; D010866:Natamycin; D003022:Clotrimazole; C020382:isoconazole
Dosiswirkungs-Untersuchungen mit dem Polyenantimykotikum Natamycin in einem galenisch neu entwickelten Ovulum bei vaginalen Hefeinfektionen.